Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker TVTX
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Eric Dube Director, Officer | TVTX Travere Therapeutics, Inc. | 243,735 | $13.0M | 10b5-1 | Oct 15, 2026 | Form 4 ↗ 4 days later · 243,735 shares | Form 144 ↗ |
| Sep 17, 2026 | Eric Dube Director, Officer | TVTX Travere Therapeutics, Inc. | 108,493 | $6.9M | 10b5-1 | Sep 17, 2026 | Form 4 ↗ same day · 400,000 shares | Form 144 ↗ |
| Sep 17, 2026 | Peter Heerma Officer | TVTX Travere Therapeutics, Inc. | 8,282 | $525.7K | 10b5-1 | Sep 17, 2026 | Form 4 ↗ same day · 283,189 shares | Form 144 ↗ |
| Sep 16, 2026 | William Rote Officer | TVTX Travere Therapeutics, Inc. | 112,850 | $7.1M | 10b5-1 | Sep 16, 2026 | Form 4 ↗ 1 day later · 209,048 shares | Form 144 ↗ |
| Sep 16, 2026 | Peter Heerma Officer | TVTX Travere Therapeutics, Inc. | 172,717 | $10.8M | 10b5-1 | Sep 16, 2026 | Form 4 ↗ 1 day later · 283,189 shares | Form 144 ↗ |
| Sep 16, 2026 | Eric Dube Director, Officer | TVTX Travere Therapeutics, Inc. | 195,841 | $12.2M | 10b5-1 | Sep 16, 2026 | Form 4 ↗ 1 day later · 400,000 shares | Form 144 ↗ |
| Sep 15, 2026 | Sandra Calvin Officer | TVTX Travere Therapeutics, Inc. | 5,375 | $353.6K | 10b5-1 | Sep 15, 2026 | Form 4 ↗ 2 days later · 5,375 shares | Form 144 ↗ |
| Sep 15, 2026 | Christopher Cline Officer | TVTX Travere Therapeutics, Inc. | 50,508 | $3.3M | 10b5-1 | Sep 15, 2026 | Form 4 ↗ 2 days later · 50,508 shares | Form 144 ↗ |
| Sep 15, 2026 | Elizabeth Reed Officer | TVTX Travere Therapeutics, Inc. | 39,576 | $2.6M | 10b5-1 | Sep 15, 2026 | Form 4 ↗ 2 days later · 37,500 shares | Form 144 ↗ |
| Sep 15, 2026 | Eric Dube Director, Officer | TVTX Travere Therapeutics, Inc. | 95,666 | $6.3M | 10b5-1 | Sep 15, 2026 | Form 4 ↗ 2 days later · 400,000 shares | Form 144 ↗ |
| Sep 15, 2026 | Peter Heerma Officer | TVTX Travere Therapeutics, Inc. | 102,190 | $6.7M | 10b5-1 | Sep 15, 2026 | Form 4 ↗ 2 days later · 283,189 shares | Form 144 ↗ |
| Sep 15, 2026 | William Rote Officer | TVTX Travere Therapeutics, Inc. | 96,198 | $6.3M | 10b5-1 | Sep 15, 2026 | Form 4 ↗ 2 days later · 209,048 shares | Form 144 ↗ |
| Sep 15, 2026 | Jula Inrig Officer | TVTX Travere Therapeutics, Inc. | 44,674 | $2.9M | 10b5-1 | Sep 15, 2026 | Form 4 ↗ 2 days later · 44,674 shares | Form 144 ↗ |
| Sep 10, 2026 | Jeffrey Meckler Director | TVTX Travere Therapeutics, Inc. | 20,000 | $1.3M | 10b5-1 | Sep 10, 2026 | Form 4 ↗ 1 day later · 20,000 shares | Form 144 ↗ |
| Aug 18, 2026 | Gary Lyons Director | TVTX Travere Therapeutics, Inc. | 5,000 | $317.6K | 10b5-1 | Aug 18, 2026 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Aug 17, 2026 | Gary A Lyons Director | TVTX Travere Therapeutics, Inc. | 5,000 | $310.7K | 10b5-1 | Aug 17, 2026 | Form 4 ↗ 2 days later · 10,000 shares | Form 144 ↗ |
| Jun 12, 2026 | Roy Baynes Director | TVTX Travere Therapeutics, Inc. | 4,500 | $225.0K | 10b5-1 | Jun 12, 2026 | Form 4 ↗ 4 days later · 4,500 shares | Form 144 ↗ |
| Jun 12, 2026 | Timothy Coughlin Director | TVTX Travere Therapeutics, Inc. | 10,000 | $500.4K | 10b5-1 | Jun 12, 2026 | Form 4 ↗ 4 days later · 10,000 shares | Form 144 ↗ |
| May 15, 2026 | Timothy Coughlin Director | TVTX Travere Therapeutics, Inc. | 3,250 | $141.2K | 10b5-1 | May 15, 2026 | Form 4 ↗ 4 days later · 3,250 shares | Form 144 ↗ |
| May 6, 2026 | Eric M. Dube Officer | TVTX Travere Therapeutics, Inc. | 22,500 | $988.9K | 10b5-1 | May 6, 2026 | Form 4 ↗ same day · 22,500 shares | Form 144 ↗ |
| May 6, 2026 | William E. Rote Officer | TVTX Travere Therapeutics, Inc. | 2,763 | $121.4K | 10b5-1 | May 6, 2026 | Form 4 ↗ same day · 2,763 shares | Form 144 ↗ |
| May 6, 2026 | Christopher Cline Officer | TVTX Travere Therapeutics, Inc. | 310 | $13.6K | 10b5-1 | May 6, 2026 | Form 4 ↗ same day · 2,491 shares | Form 144 ↗ |
| May 6, 2026 | Elizabeth Reed Officer | TVTX Travere Therapeutics, Inc. | 2,076 | $91.2K | 10b5-1 | May 6, 2026 | Form 4 ↗ same day · 24,250 shares | Form 144 ↗ |
| May 6, 2026 | Jula Inrig Officer | TVTX Travere Therapeutics, Inc. | 311 | $13.7K | 10b5-1 | May 6, 2026 | Form 4 ↗ same day · 22,485 shares | Form 144 ↗ |
| May 5, 2026 | Roy Baynes Director | TVTX Travere Therapeutics, Inc. | 4,500 | $209.9K | 10b5-1 | May 5, 2026 | Form 4 ↗ 1 day later · 4,500 shares | Form 144 ↗ |
| May 5, 2026 | Christopher Cline Officer | TVTX Travere Therapeutics, Inc. | 2,181 | $101.7K | — | May 5, 2026 | Form 4 ↗ 1 day later · 2,491 shares | Form 144 ↗ |
| May 5, 2026 | Elizabeth E. Reed Officer | TVTX Travere Therapeutics, Inc. | 2,174 | $101.4K | — | May 5, 2026 | Form 4 ↗ 1 day later · 24,250 shares | Form 144 ↗ |
| May 5, 2026 | Jula Inrig Officer | TVTX Travere Therapeutics, Inc. | 2,174 | $101.4K | — | May 5, 2026 | Form 4 ↗ 1 day later · 22,485 shares | Form 144 ↗ |
| May 5, 2026 | Peter Heerma Officer | TVTX Travere Therapeutics, Inc. | 2,174 | $101.4K | — | May 5, 2026 | Form 4 ↗ 1 day later · 2,174 shares | Form 144 ↗ |
| May 4, 2026 | Elizabeth Reed Officer | TVTX Travere Therapeutics, Inc. | 20,000 | $900.0K | 10b5-1 | May 4, 2026 | Form 4 ↗ 2 days later · 24,250 shares | Form 144 ↗ |
| May 4, 2026 | Jeffrey Meckler Director | TVTX Travere Therapeutics, Inc. | 8,000 | $360.0K | 10b5-1 | May 4, 2026 | Form 4 ↗ 2 days later · 8,000 shares | Form 144 ↗ |
| May 4, 2026 | Jula Inrig Officer | TVTX Travere Therapeutics, Inc. | 20,000 | $900.0K | 10b5-1 | May 4, 2026 | Form 4 ↗ 2 days later · 22,485 shares | Form 144 ↗ |
| May 1, 2026 | Roy Baynes Director | TVTX Travere Therapeutics, Inc. | 9,750 | $431.1K | 10b5-1 | May 1, 2026 | Form 4 ↗ 3 days later · 9,750 shares | Form 144 ↗ |
| Apr 22, 2026 | William E. Rote Officer | TVTX Travere Therapeutics, Inc. | 9,100 | $355.7K | 10b5-1 | Apr 22, 2026 | Form 4 ↗ 1 day later · 9,100 shares | Form 144 ↗ |
| Apr 15, 2026 | Eric M. Dube Officer | TVTX Travere Therapeutics, Inc. | 64,000 | $2.6M | 10b5-1 | Apr 15, 2026 | Form 4 ↗ same day · 64,000 shares | Form 144 ↗ |
| Apr 15, 2026 | Elizabeth Reed Officer | TVTX Travere Therapeutics, Inc. | 6,785 | $283.8K | 10b5-1 | Apr 15, 2026 | Form 4 ↗ same day · 51,500 shares | Form 144 ↗ |
| Apr 15, 2026 | Christopher Cline Officer | TVTX Travere Therapeutics, Inc. | 1,014 | $43.2K | 10b5-1 | Apr 15, 2026 | Form 4 ↗ same day · 8,327 shares | Form 144 ↗ |
| Apr 15, 2026 | Jula Inrig Officer | TVTX Travere Therapeutics, Inc. | 1,018 | $43.4K | 10b5-1 | Apr 15, 2026 | Form 4 ↗ same day · 8,233 shares | Form 144 ↗ |
| Apr 14, 2026 | Gary A Lyons Officer | TVTX Travere Therapeutics, Inc. | 8,000 | $245.6K | 10b5-1 | Apr 14, 2026 | Form 4 ↗ 2 days later · 8,000 shares | Form 144 ↗ |
| Apr 14, 2026 | Christopher Cline Officer | TVTX Travere Therapeutics, Inc. | 9 | $370 | 10b5-1 | Apr 14, 2026 | Form 4 ↗ 1 day later · 8,327 shares | Form 144 ↗ |
| Apr 14, 2026 | Elizabeth Reed Officer | TVTX Travere Therapeutics, Inc. | 37,500 | $1.5M | 10b5-1 | Apr 14, 2026 | Form 4 ↗ 1 day later · 51,500 shares | Form 144 ↗ |
| Apr 14, 2026 | Roy Baynes Director | TVTX Travere Therapeutics, Inc. | 32,750 | $1.4M | 10b5-1 | Apr 14, 2026 | Form 4 ↗ 2 days later · 32,750 shares | Form 144 ↗ |
| Apr 14, 2026 | Sandra Calvin Officer | TVTX Travere Therapeutics, Inc. | 21,977 | $902.6K | 10b5-1 | Apr 14, 2026 | Form 4 ↗ 2 days later · 21,977 shares | Form 144 ↗ |
| Apr 14, 2026 | Elizabeth E. Reed Officer | TVTX Travere Therapeutics, Inc. | 7,215 | $302.5K | — | Apr 14, 2026 | Form 4 ↗ 1 day later · 51,500 shares | Form 144 ↗ |
| Apr 14, 2026 | Jula Inrig Officer | TVTX Travere Therapeutics, Inc. | 7,215 | $302.5K | — | Apr 14, 2026 | Form 4 ↗ 1 day later · 8,233 shares | Form 144 ↗ |
| Apr 14, 2026 | Peter Heerma Officer | TVTX Travere Therapeutics, Inc. | 7,215 | $302.5K | — | Apr 14, 2026 | Form 4 ↗ 1 day later · 7,215 shares | Form 144 ↗ |
| Apr 14, 2026 | Christopher Cline Officer | TVTX Travere Therapeutics, Inc. | 7,239 | $303.5K | — | Apr 14, 2026 | Form 4 ↗ 1 day later · 8,327 shares | Form 144 ↗ |
| Apr 13, 2026 | Christopher Cline Officer | TVTX Travere Therapeutics, Inc. | 65 | $1,875 | — | Apr 13, 2026 | Form 4 ↗ 2 days later · 8,327 shares | Form 144 ↗ |
| Apr 6, 2026 | Roy Baynes Director | TVTX Travere Therapeutics, Inc. | 10,000 | $330.0K | 10b5-1 | Apr 6, 2026 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Apr 1, 2026 | Eric M. Dube Officer, Director | TVTX Travere Therapeutics, Inc. | 60,000 | $1.9M | 10b5-1 | Apr 1, 2026 | Form 4 ↗ 1 day later · 60,000 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:18 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances